UK markets closed

Excelsior Biopharma Inc. (6496.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
28.35+0.65 (+2.35%)
At close: 01:23PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
771,562
771,562
671,763
1,338,392
1,443,661
Cost of revenue
464,632
464,632
384,589
1,045,039
1,133,552
Gross profit
306,930
306,930
287,174
293,353
310,109
Operating expenses
Research development
62,513
62,513
42,317
55,997
57,305
Selling general and administrative
324,569
324,569
277,817
241,651
211,963
Total operating expenses
387,082
387,082
320,134
297,648
269,268
Operating income or loss
-80,152
-80,152
-32,960
-4,295
40,841
Interest expense
6,367
6,367
4,346
4,537
2,117
Income before tax
-81,951
-81,951
-25,993
-10,028
45,299
Income tax expense
9,060
9,060
7,764
5,621
9,999
Income from continuing operations
-91,011
-91,011
-33,757
-15,649
35,300
Net income
-91,011
-91,011
-33,757
-15,649
35,300
Net income available to common shareholders
-91,011
-91,011
-33,757
-15,649
35,300
Basic EPS
-2.15
-
-0.74
-0.34
0.76
Diluted EPS
-2.15
-
-0.74
-0.34
0.73
Basic average shares
45,856
-
45,618
46,511
46,667
Diluted average shares
45,856
-
45,618
46,511
49,251